Karen L. Morris

Alderley Park
Macclesfield, ENG, United Kingdom

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 20 publications

Cediranib with weekly paclitaxel or olaparib versus weekly paclitaxel for advanced or recurrent endometrial cancer (COPELIA): a multicentre, open-label, randomised, phase 2 trial in the UK.

Cediranib with weekly paclitaxel or olaparib versus weekly paclitaxel for advanced or recurrent endometrial cancer (COPELIA): a multicentre, open-label, randomised, phase 2 trial in the UK.

Journal: EClinicalMedicine

Published: April 09, 2026

EORTC 1417 - REACTION: A phase II study of etoposide and cis/carboplatin with or without pembrolizumab in untreated extensive small cell lung cancer.

EORTC 1417 - REACTION: A phase II study of etoposide and cis/carboplatin with or without pembrolizumab in untreated extensive small cell lung cancer.

Journal: European journal of cancer (Oxford, England : 1990)

Published: May 12, 2025

A Phase I Dose-escalation Study of AZD3965, an Oral Monocarboxylate Transporter 1 Inhibitor, in Patients with Advanced Cancer.

A Phase I Dose-escalation Study of AZD3965, an Oral Monocarboxylate Transporter 1 Inhibitor, in Patients with Advanced Cancer.

Journal: Clinical cancer research : an official journal of the American Association for Cancer Research

Published: July 20, 2022

Differential activity and expression of human 5β-reductase (AKR1D1) splice variants.

Differential activity and expression of human 5β-reductase (AKR1D1) splice variants.

Journal: Journal of molecular endocrinology

Published: December 03, 2020

Brief report on the clinical characteristics of patients whose samples generate small cell lung cancer circulating tumour cell derived explants.

Brief report on the clinical characteristics of patients whose samples generate small cell lung cancer circulating tumour cell derived explants.

Journal: Lung cancer (Amsterdam, Netherlands)

Published: September 04, 2020

Effect of oxaliplatin plus 5-fluorouracil or capecitabine on circulating and imaging biomarkers in patients with metastatic colorectal cancer: a prospective biomarker study.

Effect of oxaliplatin plus 5-fluorouracil or capecitabine on circulating and imaging biomarkers in patients with metastatic colorectal cancer: a prospective biomarker study.

Journal: BMC cancer

Published: July 19, 2020

Glucocorticoids regulate AKR1D1 activity in human liver in vitro and in vivo.

Glucocorticoids regulate AKR1D1 activity in human liver in vitro and in vivo.

Journal: The Journal of endocrinology

Published: December 20, 2019

Challenges in enumeration of CTCs in breast cancer using techniques independent of cytokeratin expression.

Challenges in enumeration of CTCs in breast cancer using techniques independent of cytokeratin expression.

Journal: PloS one

Published: November 03, 2016

Molecular analysis of circulating tumor cells identifies distinct copy-number profiles in patients with chemosensitive and chemorefractory small-cell lung cancer.

Molecular analysis of circulating tumor cells identifies distinct copy-number profiles in patients with chemosensitive and chemorefractory small-cell lung cancer.

Journal: Nature medicine

Published: June 08, 2016

Circulating Tumor Cells Detected in the Tumor-Draining Pulmonary Vein Are Associated with Disease Recurrence after Surgical Resection of NSCLC.

Circulating Tumor Cells Detected in the Tumor-Draining Pulmonary Vein Are Associated with Disease Recurrence after Surgical Resection of NSCLC.

Journal: Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer

Published: February 11, 2016

Identification and Targeting of Long-Term Tumor-Propagating Cells in Small Cell Lung Cancer.

Identification and Targeting of Long-Term Tumor-Propagating Cells in Small Cell Lung Cancer.

Journal: Cell reports

Published: December 21, 2015

Cediranib or placebo in combination with cisplatin and gemcitabine chemotherapy for patients with advanced biliary tract cancer (ABC-03): a randomised phase 2 trial.

Cediranib or placebo in combination with cisplatin and gemcitabine chemotherapy for patients with advanced biliary tract cancer (ABC-03): a randomised phase 2 trial.

Journal: The Lancet. Oncology

Published: April 13, 2015

Showing 1-12 of 20

Last Updated: 09/26/2026